TBPH Capital Expenditure
Theravance Biopharma Inc · Capital Expenditure

TBPH Capital Expenditure
Latest reported-$8.00Kperiod ending
TBPH CapEx (-$3.63M → -$8.00K)
Annual CapEx
High-resolution chart · PNG
TBPH capital expenditure history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Capital Expenditure (USD) |
|---|---|
| -42,000 | |
| -332,000 | |
| -2,488,000 | |
| -572,000 | |
| -3,406,000 | |
| -6,616,000 | |
| -3,176,000 | |
| -7,240,000 | |
| -2,406,000 | |
| -2,135,000 | |
| -2,647,000 | |
| -3,107,000 | |
| -2,734,000 | |
| -2,590,000 | |
| -3,627,000 |